Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-13

Clinical Trial Update: Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers [NA]

View source ↗

Summary

This document reports a clinical trial update on Artacent for treatment-resistant venous ulcers and diabetic foot ulcers, with no current status provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artacent™

Snippet

Sponsor: Tides Medical | Conditions: Venous Ulcer, Foot Ulcer, Diabetic | NA | Status: UNKNOWN